Novozymes, headquartered in Denmark, employs 6000 people and is world leader in biological solutions. Novozymes produces a wide range of industrial enzymes and microorganisms, providing innovative answers to some of the world’s most pressing challenges. Enzymes are the main part of Novozymes business, currently accounting for 90% of sales.
Novozymes’ innovative biological solutions improve industrial manufacturing processes by saving energy, water and raw materials, while reducing waste and emissions, and helping make everyday products more sustainable.
Novozymes enzymes are used in the production of laundry detergents, biofuels, food, animal feed, crops and much more. In the case of biofuels, Novozymes leads the way in cellulosic ethanol through broad partnerships that employ many feedstocks - including corn cobs, wheat straw, woody biomass, and municipal waste - and processes. The complex structure of these feedstocks is more difficult to convert into ethanol than traditional starch substrates. This has presented unique technical and economic challenges in bringing cellulosic ethanol to market. Enzymes are vital in the conversion of these feedstocks to ethanol, and Novozymes’ state-of-the-art Cellic® solutions make the technology available at a commercially viable cost. Moreover, enzyme technology for cellulosic ethanol, can create the foundation for a biobased economy, using waste and residues.
Through The BioAg Alliance, Novozymes works to discover and develop microorganisms that give the world’s farmers a new biological toolkit for increasing yields and protecting crops and has obtained a leading position in the market for seed inoculants.
Novozymes is involved in BBJ JU projects, 1 flagship and 2 research& innovation actions: ‘BIOSKOH’ (Innovation Stepping Stones for a novel European Second Generation BioEconomy), ‘EnzOx2’ (New enzymatic oxidation/oxyfunctionalization technologies for added value bio-based products) and ‘MACROCASCADE’ (Cascading Marine Macroalgal Biorefinery).